Episode Details
Back to Episodes
3 Healthcare Stocks to Avoid: Biogen, Tandem, Universal
Description
Healthcare stocks have been underperforming, with Biogen, Tandem Diabetes Care, and Universal Health Services lagging behind. Biogen, a pioneer in neuro treatments, has seen revenue and earnings decline, while Tandem Diabetes, known for smart insulin pumps, has experienced plunging earnings per share. Universal Health Services, a hospital and behavioral center operator, has faced weak patient traffic and low free cash flow margins. Despite trading cheap, these companies face significant challenges, making them less attractive investments in the healthcare sector.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/53806cebc1a0411e